Basic Information
Dalriada Drug Discovery is a contract research and collaborative discovery organization focused on translational-guided small molecule drug discovery. Dalriada offers end-to-end capabilities covering hit identification, hit-to-lead, and lead optimization, including advanced protein mass spectrometry, chemoproteomics, and full proteomics. iCLASS is Dalriada's proprietary live-cell multi-proteomics platform designed to generate cell interaction data to guide target binding and selectivity.
Dalriada Drug Discovery
Ontario,Canada
unclear
January 01, 2016
info@dalriadatx.com

